A placebo-controlled study of growth hormone in patients with congestive heart failure

European Heart Journal

Volumn 19, Issue 11, 1998, Pages 1704-1711

  Isgaard, J ^a   Bergh, C H ^a   Caidahl, Kenneth ^a   Lomsky, M ^a   Hjalmarson, Å ^a   Bengtsson, B A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Congestive heart failure; Doppler echocardiography; Growth hormone; Insulin like growth factor I; Radionuclide angiography

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DYSPNEA; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RADIONUCLIDE ANGIOGRAPHY; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0032213494     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1123     Document Type: Article

References (31)

1. [1] Cohn JN. The management of chronic heart failure. N Engl J Med 1996; 335: 490-8.
2. [2] Yang R, Bunting S, Gillett N, Clark RG, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995; 92: 262-7.
3. [3] Jin H, Yang R, Gillett N, Clark RG, Ko A, Paoni NF. Beneficial effects of growth hormone and insulin-like growth factor-I in experimental heart failure in rats treated with chronic ACE inhibition. J Cardiovasc Pharm 1995; 26: 420-5.
4. [4] Duerr RL, McKirnan D, Gim RD, Clark RG, Chien KR, Ross Jr. Cardiovascular effects of insulin-like growth factor-I and growth hormone in chronic left ventricular failure in the rat. Circulation 1996; 93: 2188-96.
5. [5] Isgaard J, Kujacic V, Jennische E et al. Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest 1997; 27: 517-25.
6. [6] Timsit J, Riou B, Bertherat J et al. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosine adenosine triphosphate activity of rat left ventricle. J Clin Invest 1990; 86: 507-15.
7. 2+ handling and enhance cardiac performance. Circ Res 1996; 79: 227-36.
8. [8] Amato G, Carella C, Fazio S et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH) deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993; 77: 1671-6.
9. [9] Caidahl K, Edén S, Bengtsson BÅ. Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994; 40: 393-400.
10. [10] Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sönksen PH. Cardiac failure responding to growth hormone hormone. Lancet 1989; i: 838-9.
11. [11] Frustaci A, Perrone GA, Gentiloni N, Russo MA. Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 1992; 97: 503-11.
12. [12] O'Driscoll JG, Green DJ, Ireland M, Kerr D, Larbalestier RI. Treatment of end-stage cardiac failure with growth hormone. Lancet 1997; 349: 1068.
13. [13] Fazio S, Sabatini D, Capaldo B et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 334: 809-14.
14. [14] Volterrani M, Desenzani P, Lorusso R, d'Aloia A, Manelli F, Giustina A. Haemodynamic effects of intra venous growth hormone in congestive heart failure. Lancet 1997; 349: 1067-8.
15. [15] Criteria Committee, New York Heart Association Inc. Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. 6th edn. Boston, Little, Brown and Co 1964, p. 114.
16. [16] Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. Second edn. Geneva: WHO, 1982.
17. [17] Zipes D. Specific arrhythmias: diagnosis and treatment. In: Braunwald E (ed.): Heart disease: a textbook of cardiovascular medicine, 5th edn. Philadelphia: W B Saunders Co 1997: 640-704.
18. [18] Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
19. [19] Reichek N, Wilson J, Sutton MSJ, Plappert TA, Goldberg S, Hirschfeld JW. Noninvasive determination of left ventricular end-systolic wall stress. Validation of the method and initial applications. Circulation 1982; 65: 99-108.
20. [20] Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo 1989; 2: 358-67.
21. [21] Caidahl K, Eriksson H, Hartford M et al. Dyspnoea of cardiac origin in 67 year old men: (2). Relation to diastolic left ventricular function and mass. The study of men born in 1913. Br Heart J 1988; 59: 329-38.
22. [22] Porter WC, Dees SM, Freitas JE, Dworkin HJ. Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells. J Nucl Med 1983; 31: 450-6.
23. [23] Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med 1990; 31: 450-6.
24. [24] Cittadini A, Strömer H, Katz SE, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat. A combined in vivo and in vitro evaluation. Circulation 1996; 93: 800-9.
25. [25] Shen YT, Wiedmann RT, Lynch JJ, Grossman W, Johnson RG. GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction. Am J Physiol 1996; 271: H1721-7.
26. [26] Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endo Rev 1994; 15: 555-73.
27. [27] Johannsson G, Bengtsson B-Å, Andersson B, Isgaard J, Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH deficient adults. Preliminary data in a small group of patients. Clin Endocrinol 1996; 45: 305-14.
28. [28] Beer N, Tortoledo F, Beer R, Pinedo M, Fermin E. Beneficial effects of growth hormone in patients with chagas cardiomyopathy and dilated cardiomyopathy of unknown etiology (Abstr). Circulation 1997; 96 (Suppl 1): I-521 (2920).
29. [29] Turner H, Wass JAH. Growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 335: 672.
30. [30] Frustaci A, Gentiloni N, Russo MA. Letter to the Editor. N Engl J Med. 1996; 335: 672-3.
31. [31] Isgaard J, Carlsson L, Isaksson OGP, Jansson J-O. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomised rats increases insulin-like growth factor I messenger ribonucleic acid more effectively than continuous GH infusion. Endocrinology 1988; 123: 2605-10.